首页 | 本学科首页   官方微博 | 高级检索  
     


Genome scan meta-analysis of schizophrenia and bipolar disorder,part II: Schizophrenia
Authors:Lewis Cathryn M  Levinson Douglas F  Wise Lesley H  DeLisi Lynn E  Straub Richard E  Hovatta Iiris  Williams Nigel M  Schwab Sibylle G  Pulver Ann E  Faraone Stephen V  Brzustowicz Linda M  Kaufmann Charles A  Garver David L  Gurling Hugh M D  Lindholm Eva  Coon Hilary  Moises Hans W  Byerley William  Shaw Sarah H  Mesen Andrea  Sherrington Robin  O'Neill F Anthony  Walsh Dermot  Kendler Kenneth S  Ekelund Jesper  Paunio Tiina  Lönnqvist Jouko  Peltonen Leena  O'Donovan Michael C  Owen Michael J  Wildenauer Dieter B  Maier Wolfgang  Nestadt Gerald  Blouin Jean-Louis  Antonarakis Stylianos E  Mowry Bryan J  Silverman Jeremy M
Affiliation:1 Division of Genetics and Development, Guy’s, King’s &; St Thomas’ School of Medicine, London
2 Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London
3 Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia
4 New York University Medical Center, New York
5 Department of Psychiatry, Columbia University, New York
6 Department of Psychiatry, Mt. Sinai School of Medicine, New York
7 Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, Bethesda
8 Department of Molecular Medicine, National Public Health Institute, Biomedicum,
9 Department of Mental Health, National Public Health Institute, Helsinki
10 Department of Medical Genetics, University of Helsinki, Biomedicum, Helsinki
11 Department of Psychological Medicine, University of Wales College of Medicine, Cardiff, United Kingdom
12 Department of Psychiatry, University of Bonn, Bonn, Germany
13 Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore
14 Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston
15 Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Boston
16 Department of Genetics, Rutgers University, Piscataway, NJ
17 Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ
18 Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine and Louisville Veterans Affairs Medical Center, Louisville, KY
19 Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
20 University of Utah, Salt Lake City
21 Molecular Genetics Laboratory, Department of Psychiatry and Psychotherapy, University Hospital Schleswig-Holstein, Kiel, Germany
22 Department of Psychiatry, University of California, Irvine
23 DNA Sciences, Fremont, CA
24 Hospital Nacional Psiquiatrico, Pavas, San Jose, Costa Rica
25 Xenon Genetics, Burnaby, Canada
26 The Department of Psychiatry, The Queens University, Belfast, Northern Ireland
27 The Health Research Board, Dublin, Ireland
28 Department of Psychiatry and Human Genetics, Virginia Commonwealth University, Richmond
29 Department of Human Genetics, University of California, Los Angeles
30 Department of Medical Genetics, University of Geneva Medical School, Centre Médical Universitaire, Geneva, Switzerland
31 Queensland Centre for Schizophrenia Research, Wolston Park Hospital, Wacol, Australia
32 Department of Psychiatry, University of Queensland, Brisbane, Australia
33 Mental Health Clinical Research Center and Department of Psychiatry, The University of Iowa College of Medicine, Iowa City
34 Department of Psychiatry, Washington University, St. Louis
35 Department of Psychiatry, University of Toronto, Toronto
36 Department of Psychiatry, General Hospital, Iceland
37 Department of Psychiatry, National University Hospital, Reykjavik, Iceland
Abstract:
Schizophrenia is a common disorder with high heritability and a 10-fold increase in risk to siblings of probands. Replication has been inconsistent for reports of significant genetic linkage. To assess evidence for linkage across studies, rank-based genome scan meta-analysis (GSMA) was applied to data from 20 schizophrenia genome scans. Each marker for each scan was assigned to 1 of 120 30-cM bins, with the bins ranked by linkage scores (1 = most significant) and the ranks averaged across studies (R(avg)) and then weighted for sample size (N(sqrt)[affected casess]). A permutation test was used to compute the probability of observing, by chance, each bin's average rank (P(AvgRnk)) or of observing it for a bin with the same place (first, second, etc.) in the order of average ranks in each permutation (P(ord)). The GSMA produced significant genomewide evidence for linkage on chromosome 2q (PAvgRnk<.000417). Two aggregate criteria for linkage were also met (clusters of nominally significant P values that did not occur in 1,000 replicates of the entire data set with no linkage present): 12 consecutive bins with both P(AvgRnk) and P(ord)<.05, including regions of chromosomes 5q, 3p, 11q, 6p, 1q, 22q, 8p, 20q, and 14p, and 19 consecutive bins with P(ord)<.05, additionally including regions of chromosomes 16q, 18q, 10p, 15q, 6q, and 17q. There is greater consistency of linkage results across studies than has been previously recognized. The results suggest that some or all of these regions contain loci that increase susceptibility to schizophrenia in diverse populations.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号